Oxervate and Blepharitis - a phase IV clinical study of FDA data

Summary:

Blepharitis is reported as a side effect among people who take Oxervate (cenegermin-bkbj), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Aspirin, and have Neurotrophic keratopathy.

The phase IV clinical study analyzes which people have Blepharitis when taking Oxervate. It is created by eHealthMe based on reports of 7,219 people who have side effects when taking Oxervate from the FDA, and is updated regularly.

What is Oxervate?

Oxervate has active ingredients of cenegermin-bkbj. eHealthMe is studying from 7,219 Oxervate users. Check the latest studies of Oxervate.

What is Blepharitis?

Blepharitis (chronic inflammation of the eyelid) is found to be associated with 512 drugs and 690 conditions by eHealthMe. Check the latest studies of Blepharitis.

On Aug, 01, 2026

7,219 people reported to have side effects when taking Oxervate.
Among them, 18 people (0.25%) have Blepharitis.

Among these 18 people:

How long have people been on Oxervate when they have Blepharitis? *

What is the gender of people who have Blepharitis when taking Oxervate? *

female: 55.56 %
male: 44.44 %

What is the age of people who have Blepharitis when taking Oxervate? *

What are other drugs people take besides Oxervate? *

Vitamin D3: 5 people, 27.78%
Aspirin: 5 people, 27.78%
Erythromycin: 4 people, 22.22%
Simvastatin: 4 people, 22.22%
Zioptan: 3 people, 16.67%
Xiidra: 3 people, 16.67%
Eliquis: 3 people, 16.67%
Pepcid: 3 people, 16.67%
Atorvastatin Calcium: 3 people, 16.67%
Tamsulosin Hydrochloride: 2 people, 11.11%

What are other side effects people have besides Blepharitis? *

Eye Pain: 10 people, 55.56%
Eyelid Pain: 7 people, 38.89%
Erythema Of Eyelid (redness of the eyelid): 6 people, 33.33%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 4 people, 22.22%
Eyelid Irritation: 3 people, 16.67%
Eye Swelling: 3 people, 16.67%
Eye Irritation: 3 people, 16.67%
Eye Discharge: 2 people, 11.11%
Photophobia (extreme sensitivity to light): 2 people, 11.11%
Lacrimation Increased: 2 people, 11.11%

What are the existing conditions these people have? *

Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 14 people, 77.78%
Ulcerative Keratitis (ulcerative inflammation of the cornea): 3 people, 16.67%
Hypoaesthesia Eye (reduced sense of touch or sensation on eyes): 2 people, 11.11%
Stable Angina (a constant chest pain): 1 person, 5.56%
Keratitis (eye's cornea, the front part of the eye, becomes inflamed): 1 person, 5.56%
Dry Eyes (lack of adequate tears): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Oxervate and have Blepharitis?

- Check whether Blepharitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Oxervate:

Oxervate (7,219 reports)

Blepharitis treatments and more:

Blepharitis (5,399 reports)

Browse all side effects of Oxervate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blepharitis:

Blepharitis (513 drugs)

Browse all the conditions that are associated with Blepharitis:

Blepharitis (690 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cenegermin-bkbj (the active ingredients of Oxervate) and Oxervate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.